close
close
Neurogen defines a large schedule for the health conference for March 2024

Neurogen defines a large schedule for the health conference for March 2024

by





Neurogens (Nasdaq: Ngne)A company in clinical level that focuses on the development of genetic drugs for rare neurological diseases has announced its participation in three upcoming health conferences in March.

The company will be on:

  • The TD COWEN 45th annual health conference on March 3 at 9:50 a.m.
  • The Empty LINK GLOBAL Healthcare Conference on March 10th at 1:00 p.m.
  • The Stifel Virtual CNS Forum on March 19 at 9:30 a.m.

Management will lead to Fireside chats at all three events, whereby additional investor sessions for the TD cowen and empty links are planned. Live -Webcasts of the Fireside chats will be available from the “Investor Relations” section of the website of neurogens, with repetitions available for a time.

Neurogens (Nasdaq: Ngne)Un'azienda in the Fase Clinica Focalizzata Nello Sviluppo di Medicinali Genetici Pro Malattie Neurological, ha anunciato la sua partecipazione a Tre Conference Sanitary in Programma a Marzo.

L'Azienda Parteciperà a:

  • La 45ª Conferenza Annual Sulla Salute di td cowen IL 3 Marzo all 9:50 et
  • La Conference Globale Sulla Salute di empty left IL 10 Marzo all 13:00 et
  • IL Forum Virtual CNS Di Stifel IL 19 Marzo All 9:30 ET

La Direzione Parteciperà a Discussions Informali in Tute E Tre Le Manifestazioni, con ulerori incontri con gli investori programming pro le conferenze di td cowen e empty. Le Tremissioni in Diretta dellen Discussioni informali Saranno Disponibili nella sezione relazioni con gli investori del sito web di neurogenic, con Repliche Disponibili Pro un -certificate periodo.

Neurogens (Nasdaq: Ngne)Una empresa en etapa clínica enfocada en desarrollar medicament genéticos para enfermedades neurológicas raras, ha anunciado su practición en tres presencias de salud en marzo.

La Empesa Particalará en:

  • La 45ª Conferencia Anual de Attención Médica de Td Cowen El 3 de Marzo a Las 9:50 a.m.
  • La Conferencia Global de Salud de empty link El 10 de Marzo a la 13:00
  • Tin Virtual CNS de Stifel EL 19 de Marzo a Las 9:30 a.m.

La Dirección Particalará en charlas informal en los tres eventos, con reuniones adicionales con Inverores programadas para las conferencias de td cowen y empty. Las Transmisiones EN Vivo de Las Charlas Informales Estarán Disponibles A Través de la Sección de Relaciones Consultores del Sitio Web de Neurogen, Conpetical Disponibles POR un Tiempo.

뉴로진 (네덜란드: Ngne)희귀 신경 위한 유전자 개발하는 회사가 회사가 회사가 월에 월에 월에 회의에 회의에 참여한다고 발표했습니다 발표했습니다 발표했습니다 발표했습니다 발표했습니다 발표했습니다 발표했습니다 월에 월에 개발하는 의 단계의 단계의 단계의 발표했습니다 발표했습니다 발표했습니다 발표했습니다 임상 발표했습니다 발표했습니다 발표했습니다 발표했습니다 발표했습니다 발표했습니다 발표했습니다 발표했습니다 발표했습니다 단계의 단계의 단계의 단계의 단계의 단계의 단계의 단계의 단계의 단계의 단계의 단계의 단계의 단계의 단계의 단계의 단계의 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 회사가 월에 예정된 세 개의 의료 회의에 회의에 회의에 회의에 회의에 회의에 회의에 회의에 회의에 회의에

회사는 다음 회의에 참여할:

  • Td cowen 제 45 회 회 의료 회의 회의가 3 월 3 일 9 시 50 분 et 에.
  • 리어링크 글로벌 회의 회의가 3 월 10 일 1 시 et 에.
  • 스티펠 가상 cns 포럼이 3 월 19 일 9 시 30 분 et 에.

경영진은 세 가지 이벤트 대화형 세션에 참여하며 참여하며 및 및 리어링크 리어링크 리어링크 회의가 회의가 있습니다 있습니다 있습니다 대화형 웹캐스트는 관계 섹션을 섹션을 섹션을 섹션을 통해 통해 기간 동안 가능합니다 가능합니다 가능합니다 가능합니다.

Neurogens (Nasdaq: Ngne)Une entrepreneur and phase clinique axée sur le dévelopement de médicamente génétiques Possen Maladies neurologiques rares rares, an annoncé sa -Trois conférenences de santé à venir en mars.

L'Erprise Partizipera à:

  • La 45e Conférence Annuelle de Soins de Santé de td cowen Le 3 Mars à 9h50 et
  • La Conférence Mondiale de Says de Santé de empty left Le 10 Mars à 13h00 et
  • Le Forum Virtuel CNS de Stifel Le 19 Mars à 9H30 et

La Direction Breakter of the Discussions Informal Lor of the Trois Événement, Avec des Réunion Supplémentaires Avec les Investmentors Prévues Possen Les Conférences de Td Cowen et de empty canal. Les webcasts en direct of the discussions informal seront disponibles dans la section relationships investmentors du site web de neurogen, avec of the rediffusion disponipbles counterpart and certain temperatures.

Neurogens (Nasdaq: Ngne)A clinical company that focuses on the development of genetic drugs for rare neurological diseases, hats his participation and Drei -pending health health conferences Immrz

Participate in the company with a subsequent conferences:

  • The 45. Landy health conference from TD Cowen On March 3 at 9:50 a.m.
  • The Empty LINK GLOBAL Healthcare Conference on March 10th at 1:00 p.m.
  • Dem Stifel Virtual CNS Forum On March 19 at 9:30 a.m.

Management will participate in an informal discussions to all three events, whereby additional investor meetings for the conferences of TD COWEN and empty link are. Live webcasts of informal conversations will be in the Berich-Investor relationships of the Neurogen Verefar website, recreational to the best time.











NEW YORK-(Business Wire)-Neurogens Inc. (Nasdaq: Ngne), a company in the clinical stadium that was founded, conferences: conferences are affected by rare neurological diseases:

TD COWEN 45th annual health conference

Format: Management will participate in a Fireside chat and investor meetings

Date: Monday, March 3 at 9:50 a.m.

Empty LINK GLOBAL Healthcare Conference

Format: Management will participate in a Fireside chat and investor meetings

Date: Monday, March 10th at 1:00 p.m.

Stifel Virtual CNS Forum

Format: Management will participate in a Fireside chat

Date: Wednesday, March 19 at 9:30 a.m.

Live -Webcasts of the Fireside chats are accessible under events on events on the “Investor Relations” section, which will also be available to repeat the events for a limited time.

About neurogen

The mission of the neurogen is to treat devastating neurological diseases in order to improve the life of patients and families affected by these rare diseases. Neurogen develops new approaches and treatments in order to tackle the limits of conventional gene therapy in the event of disorders of the central nervous system. This includes the selection of a delivery approach to maximize the distribution of target tissue and the design of products in order to maximize potency and purity for an optimized effectiveness and safety profile. The company's new and proprietary, exact transgen regulatory platform technology enables the provision of therapeutic values ​​and a limitation of the transgentoxicity associated with conventional gene therapy. The neurogen has constructed a state-of-the-art genetic therapy manufacturing facility Houston, Texas. CGMP production of NGN-401 was carried out in this facility and will support central clinical development activities. You can find more information at www.neurogene.com.

Corporate contact:

Cara Mayfield

Vice President, corporate matters

cara.mayfield@neurogen.com

Investor contact:

Melissa Forst

Argot partner

Neurogene@argotpartners.com

Source: Neurogenic Inc.








FAQ



What conferences will neurogen (NGNE) take part in March 2024?

Neurogens will take part in three conferences: TD COWEN 45th annual health conference (March 3), empty link Global Healthcare Conference (March 10) and Stifel Virtual CNS Forum (March 19).


How can investors access the conference presentations (NGNE) to neurogens (NGNE)?

Investors can access the “Investor Relations” section of the neurogenic website under events, whereby repetitions will also be available for a time.


What kind of presentations will neurogen (NGNE) give at these health conferences?

Neurogenic management will take part in Fireside chats in all three conferences, whereby additional investor meetings for the TD cowen and empty links are planned.


What is the schedule for the conference presentations of neurogens (NGNE) March 2024?

The presentations are planned for March 3 at 9:50 a.m. ET (TD Cowen), March 10th at 1:00 p.m. ET (empty left) and March 19 at 9:30 a.m. ET (Stifel).





Related posts:

Nebraska dropped Tennessee to facilitate College Football Playoff -Weg

The man in the death cell dies weeks before the execution date in Louisiana

Scheidt binds a career -triple record in Douleheader